Skip to main content
SpringerLink
Log in
Book cover

Cardiac Drug Therapy pp 1–68Cite as

Beta-Blockers

The Cornerstone of Cardiac Drug Therapy

  • Chapter
  • First Online:

Part of the book series: Contemporary Cardiology ((CONCARD))

Abstract

This chapter tells you

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • BHAT;β-Blocker Heart Attack Trial Research Group. A randomised trial of propranolol in patients with acute myocardial infarction. I: mortality results. JAMA. 1982;247:1707–14.

    Article  Google Scholar 

  • Black JW, Crowther AF, Shanks RG, et al. A new adrenergic beta-receptor-antagonist. Lancet. 1964;2:1080.

    Article  Google Scholar 

  • Boissel JP, Leizorovicz A, Picolet H, et al. Efficacy of acebutolol after acute myocardial infarction (the APSI Trial). Am J Cardiol. 1990;66:24C.

    Article  CAS  PubMed  Google Scholar 

  • Boucek RJ, Gunja-Smith Z, Noble NL, et al. Modulation by propranolol of the lysyl cross-links in aortic elastin and collagen of the aneurysm-prone turkey. Biochem Pharmacol. 1983;32:275.

    Article  CAS  PubMed  Google Scholar 

  • Boydak B, Nalbantgil S, Fici F, et al. A randomised comparison of the effects of nebivolol and atenolol with and without chlorthalidone on the sexual function of hypertensive men. Clin Drug Investig. 2005;25:409–16.

    Article  CAS  PubMed  Google Scholar 

  • Braunwald E. Mechanism of action of calcium-channel-blocking agents. N Engl J Med. 1982;307:1618.

    Article  CAS  PubMed  Google Scholar 

  • Breckenridge A. Jogger’s blockade. Br Med J. 1982;284:532.

    Article  CAS  Google Scholar 

  • Brixius K, Middeke M, Lichtenthal A, et al. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol. 2007;34:327–31.

    Article  CAS  PubMed  Google Scholar 

  • Brophy CM, Tilson JE, Tilson MD. Propranolol stimulates the crosslinking of matrix components in skin from the aneurysm-prone blotchy mouse. J Surg Res. 1989;46:330.

    Article  CAS  PubMed  Google Scholar 

  • CAPRICORN: The Capricorn Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction. Lancet. 2001;357:1385.

    Article  Google Scholar 

  • Chan AW, Quinn MJ, Bhatt DL, et al. Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention. J Am Coll Cardiol. 2002;40:669–75.

    Article  PubMed  Google Scholar 

  • Chockalingam P, Crotti L, Girardengo G, et al. Not all beta-blockers are equal in the management of long qt syndrome types 1 and 2: higher recurrence of events under metoprolol. J Am Coll Cardiol. 2012;60(20):2092–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Clark JA, Zimmerman HF, Tanner LA. Labetalol hepatotoxicity. Ann Intern Med. 1990;113:210.

    Article  CAS  PubMed  Google Scholar 

  • Cockcroft JR, Chowienczyk PJ, Brett SE, et al. Nebivolol vasodilates human forearm vasculature: evidence for a L-arginine/No-dependent mechanism. J Pharmacol Exp Ther. 1995;274:1067–71.

    CAS  PubMed  Google Scholar 

  • Cominacini L, Pasini AF, Garbin U, et al. Nebivolol and its 4-keto derivative increase nitric oxide in endothelial cells by reducing its oxidative inactivation. J Am Coll Cardiol. 2003;42:1838–44.

    Article  CAS  PubMed  Google Scholar 

  • COPERNICUS, Packer M, Coast JS, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651.

    Article  CAS  PubMed  Google Scholar 

  • Cray RJ, Bateman TM, Czer LS, et al. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in post-operative supraventricular tachyarrhythmias. J Am Coll Cardiol. 1985;5:1451.

    Article  Google Scholar 

  • Cruickshank JM, Degaute JP, Kuurne T, et al. Reduction of stress/catecholamine induced cardiac necrosis by B1 selective blockade. Lancet. 1987;2:585.

    Article  CAS  PubMed  Google Scholar 

  • Cruickshank JM. Beta-blockers continue to surprise us. Eur Heart J. 2000;21:355.

    Article  Google Scholar 

  • Cunnane JG, Blackwood GW. Psychosis with propranolol: still not recognized? Postgrad Med J. 1987;63:57.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Deanfield J, Wright C, Krikler S. Cigarette smoking and the treatment of angina with propranolol, atenolol and nifedipine. N Engl J Med. 1984;310:951.

    Article  CAS  PubMed  Google Scholar 

  • Devreux RB. Do antihypertensive drugs differ in their abilities to regress left ventricular hypertrophy? Circulation. 1997;95:1983.

    Article  Google Scholar 

  • Edes I, Gasior Z, Wita K. Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study. Eur J Heart Fail. 2005;7(4):631–9.

    Article  CAS  PubMed  Google Scholar 

  • Engler RL, Conant J, Maisel A, et al. Lipid solubility determines the relative CNS effects of beta-blocking agents. J Am Coll Cardiol. 1986;7:25A.

    Article  Google Scholar 

  • Flather MD, Shibata MC, Coats AJ, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in the elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26:215–25.

    Article  CAS  PubMed  Google Scholar 

  • Fleischmann KE, Beckman JA, Buller CE, et al. 2009 ACCF/AHA focused update on perioperative beta blockade: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;54:2102–28.

    Article  PubMed  Google Scholar 

  • Frishman WH. Beta-adrenergic blocking drugs. Am Coll Cardiol Curr J Rev. 1997;23.

    Google Scholar 

  • GEMINI, Bakris GL, Fonseca V, Katholi RE, et al. Metabolic effects of carvedilol vs. metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA. 2004;292:2227–36.

    Article  CAS  PubMed  Google Scholar 

  • Gorczynski RJ. Basic pharmacology of esmolol. Am J Cardiol. 1985;56:3F.

    Article  CAS  PubMed  Google Scholar 

  • Goyal A, Spertus JA, Gosch K, et al. Serum potassium levels and mortality in acute myocardial infarction. JAMA. 2012;307(2):157–64.

    Article  CAS  PubMed  Google Scholar 

  • Gray CL, Ndefo UA. Nebivolol: a new antihypertensive agent. Am J Health Syst Pharm. 2008a;65(12):1125–33.

    Article  CAS  PubMed  Google Scholar 

  • Handlin LR, Kindred LH, Beauchamp GD, et al. Reversible left ventricular dysfunction after subarachnoid hemorrhage. Am Heart J. 1993;126:235.

    Article  CAS  PubMed  Google Scholar 

  • Hjalmarson A, Herlitz J, Malek I. Effect on mortality of metoprolol in acute myocardial infarction. Lancet. 1981;2:823.

    Article  CAS  PubMed  Google Scholar 

  • International Collaborative Study Group. Reduction of infarct size with early use of timolol in acute myocardial infarction. N Engl J Med. 1984;310:9.

    Article  Google Scholar 

  • Johansson BW. Effect of beta-blockade on ventricular fibrillation and tachycardia induced circulatory arrest in acute myocardial infarction. Am J Cardiol. 1986;57:34F.

    Article  CAS  PubMed  Google Scholar 

  • Julian DG. Is the use of beta-blockade contraindicated in the patient with coronary spasm? Circulation. 1983;67(Suppl):1.

    Google Scholar 

  • Kaumann AJ. Some aspects of heart beta adrenoceptor function. Cardiovasc Drugs Ther. 1991;5:549.

    Article  CAS  PubMed  Google Scholar 

  • Khan MG. Clinical trials. In: Khan MG, Cardiac Drug Therapy. Philadelphia: WB Saunders; 2003. p. 502.

    Google Scholar 

  • Khan MG. Hypertension. In: Khan MG, Encyclopedia of heart diseases. New York: Springer; 2011. p. 556.

    Chapter  Google Scholar 

  • Khan MG. Which beta blocker to choose. In: Khan MG, Heart disease diagnosis and therapy. 2nd ed. Totowa, NJ: Humana Press; 2005.

    Chapter  Google Scholar 

  • Khan MG. Angina. In: Khan MG. Heart disease, diagnosis and therapy. Baltimore, MD: Williams & Wilkins; 1996a.

    Google Scholar 

  • Khan MG. Hyperlipidemia. In: Khan MG. Heart disease, diagnosis and therapy. Baltimore, MD: Williams & Wilkins; 1996b. p. 384.

    Google Scholar 

  • Khan MG, Topol EJ. Angina. In: Khan MG. Heart disease, diagnosis and therapy, a practical approach. Baltimore, MD: Williams and Wilkins; 1996. p. 157.

    Google Scholar 

  • Khan MI, Hamilton JT, Manning GW. Protective effect of beta adrenoceptor blockade in experimental coronary occlusion in conscious dogs. Am J Cardiol. 1972;30:832.

    Article  CAS  PubMed  Google Scholar 

  • Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-termmyocardial infarction intervention trials. Am J Cardiol. 1986;57:43F.

    Article  CAS  PubMed  Google Scholar 

  • Kleiger RE, Miller JP, Bigger JT, et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256.

    Article  CAS  PubMed  Google Scholar 

  • Kokkinos P, Chrysohoou C, Panagiotakos D, et al. Beta-blockade mitigates exercise blood pressure in hypertensive male patients. J Am Coll Cardiol. 2006;47:794–8.

    Article  CAS  PubMed  Google Scholar 

  • Kostis JB, Rosen RC. Central nervous system effects of beta-adrenergic blocking drugs: the role of ancillary properties. Circulation. 1987;75:204.

    Article  CAS  PubMed  Google Scholar 

  • Krum H, Gu A, Wiltshire-Clement M, et al. Changes in plasma endothelin-1 levels reflects clinical response to β-blockade in chronic heart failure. Am Heart J. 1996;131:337.

    Article  CAS  PubMed  Google Scholar 

  • Lacro RV, Dietz HC, Wruck LM, et al. Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J. 2007;154:624–31.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lee JH, Bae MH, Chae SC, et al. The benefit of beta-blocker therapy in hospital survivors receiving primary percutaneous coronary intervention after ST-elevation myocardial infarction from the Korea acute myocardial infarction registry. J Am Coll Cardiol. 2012;60(17_S). doi:10.1016/j.jacc.2012.08.753.

  • Lindholm LH, Carlberg B, Samuelsson O. Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet. 2005;366:1545–53.

    Article  CAS  PubMed  Google Scholar 

  • Maffei A, Lembo G. Nitric oxide mechanisms of nebivolol. Ther Adv Cardiovasc Dis. 2009;3(4):317–27.

    Article  PubMed  Google Scholar 

  • Man in’t Veld AJ, Van den Meiracker AH, Schalekamp MA. Do beta-blockers really increase peripheralvascular resistance? Review of the literature and new observations under basal conditions. Am J Hypertens. 1988;1:91.

    Article  PubMed  Google Scholar 

  • Matterson BJ, Reda DJ, Cushman WC, et al. Single drug therapy for hypertensive men: a comparison of 6 hypertensive agents with placebo. N Engl J Med. 1993;328:914.

    Article  Google Scholar 

  • Medical Research Council Working Party on Mild to Moderate Hypertension. Bendrofluazide and propranolol for the treatment of mild hypertension. Lancet. 1981;2:359.

    Google Scholar 

  • Medical Research Council Working Party. MRC trial of treatment of hypertension in older adults: principal results. BMJ. 1992;304:405.

    Article  Google Scholar 

  • MERIT-HF Study Group. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure. Analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF). J Am Coll Cardiol. 2002;40:491–8.

    Article  Google Scholar 

  • MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL Randomized Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001.

    Article  Google Scholar 

  • Motomura S, Zerkowski HR, Daul A, et al. On the physiologic role of beta-2 adrenoceptors in the human heart: in vitro and in vivo studies. Am Heart J. 1990;119:608.

    Article  CAS  PubMed  Google Scholar 

  • Münzel T, Gori T. Nebivolol. The somewhat-different b-adrenergic receptor blocker. J Am Coll Cardiol. 2009;54:1491–9.

    Article  PubMed  Google Scholar 

  • Multi Center Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med. 1988;319:385.

    Article  Google Scholar 

  • Neutel JM, Smith DHG, Ram CVS. Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents. Am J Med. 1993;94:181.

    Article  CAS  PubMed  Google Scholar 

  • Packer M, Bristol MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349.

    Article  CAS  PubMed  Google Scholar 

  • Pasotti C, Zoppi A, Capra A. Effect of beta-blockers on plasma lipids. Int J Clin Pharmacol Ther Toxicol. 1986;24:448.

    CAS  PubMed  Google Scholar 

  • Peters RW, Muller JE, Goldstein S, et al. Propranolol and the morning increase in the frequency of sudden cardiac deaths (BHAT Study). Am J Cardiol. 1989;63:1518.

    Google Scholar 

  • Phillips T, Anlauf M, Distler A, et al. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. BMJ. 1997;315:154.

    Article  Google Scholar 

  • Pitt B. Regression of left ventricular hypertrophy in patients with hypertension: blockade of the reninangiotensin- aldosterone system. Circulation. 1998;98:1987.

    Article  CAS  PubMed  Google Scholar 

  • Pitt B. The role of beta-adrenergic blocking agents in preventing sudden cardiac death. Circulation. 1992;85(Suppl I):I107.

    CAS  PubMed  Google Scholar 

  • POISE trial, Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery; a randomised controlled trial. Lancet. 2008;371:1839–47.

    Article  CAS  PubMed  Google Scholar 

  • Pizarro G, Fuster F-FL, et al. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute MI: results from the METOCARD-CNTC trial (effect of metoprolol in cardioprotection during an acute myocardial infarction. J Am Coll Cardiol. 2014;63(22):2356–62.

    Article  CAS  PubMed  Google Scholar 

  • Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med. 1999;341:1789.

    Article  CAS  PubMed  Google Scholar 

  • Ponce FE, Williams LC, Webb HM, et al. Propranolol palliation of tetralogy of Fallot: experience with long-term drug treatment in pediatric patients. Pediatrics. 1973;52:100.

    CAS  PubMed  Google Scholar 

  • Pratt CM, Roberts R. Chronic beta-blockade therapy in patients after myocardial infarction. Am J Cardiol. 1983;52:661.

    Article  CAS  PubMed  Google Scholar 

  • Pritchard BNC, Gillam PMS. The use of propranolol in the treatment of hypertension. BMJ. 1964;2:725.

    Article  Google Scholar 

  • Pyeritz RE. Marfan syndrome and related disorders. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR, editors. Emery and Rimoin’s principles and practice of medical genetics, vol. 3. 5th ed. London: Churchill Livingstone; 2007. p. 3579–624.

    Google Scholar 

  • Raeder EA, Verrier RL, Lown B. Intrinsic sympathomimetic activity and the effects of beta-adrenergic blocking drugs on vulnerability to ventricular fibrillation. J Am Coll Cardiol. 1983;1:1442.

    Article  CAS  PubMed  Google Scholar 

  • Rothfield EL, Lipowitz M, Zucker IR, et al. Management of persistently recurring ventricular fibrillation with propranolol hydrochloride. JAMA. 1968;204:546.

    Article  Google Scholar 

  • Ryden L, Ariniego R, Arnman K, et al. A double-blind trial of metoprolol in acute myocardial infarction: effects on ventricular tachyarrhythmias. N Engl J Med. 1983;308:614.

    Article  CAS  PubMed  Google Scholar 

  • Savola J, Vehvilainen O, Vaatainen NJ. Psoriasis as a side effect of beta-blockers. BMJ. 1987;295:637.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Second Cardiac Insufficiency Bisoprolol Study (CIBIS II). Presented by E. Merck at the 20th Congress of the European Society of Cardiology, Aug 1998, Vienna, Austria.

    Google Scholar 

  • Shore SJ, Berger KR, Murphy EA, et al. Progression of aortic dilation and the benefit of long-term betaadrenergic blockade in Marfan’s syndrome. N Engl J Med. 1994;330:1335.

    Article  Google Scholar 

  • Short et al. Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ. 2011;342:d2549.

    Google Scholar 

  • Singh BN. Advantages of beta-blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction. Am J Cardiol. 1990;66:9C.

    Article  CAS  PubMed  Google Scholar 

  • Sixth Report of Joint National Committee on Prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1997;157:2413.

    Google Scholar 

  • Sloman G, Robinson JS, McLean K. Propranolol (Inderal) in persistent ventricular fibrillation. BMJ. 1965;5439:895.

    Article  Google Scholar 

  • SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685–91.

    Google Scholar 

  • Sorrentino SA, Doerries C, Manes C, et al. Nebivolol Exerts Beneficial Effects on Endothelial Function, Early Endothelial Progenitor Cells, Myocardial Neovascularization, and Left Ventricular Dysfunction Early After Myocardial Infarction Beyond Conventional β1-Blockade. J Am Coll Cardiol. 2011;57:601–11.

    Article  CAS  PubMed  Google Scholar 

  • Steinbeck G, Andresen D, Bach P, et al. A comparison of electrophysiologically guided anti-arrhythmic drug therapy with beta-blocker therapy in patients with symptomatic sustained ventricular tachyarrhythmias. N Engl J Med. 1992;327:987.

    Article  CAS  PubMed  Google Scholar 

  • The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981;304:801.

    Article  Google Scholar 

  • Theodorakis JM, Kremastinos T, Stephanokis GS, et al. The effectiveness of beta-blockade and its influence on heart rate variability in vasovagal patients. Eur Heart J. 1993;14:1499.

    Article  CAS  PubMed  Google Scholar 

  • Tuncer M, Fettser DV, Gunes Y, et al. Comparison of effects of nebivolol and atenolol on P-wave dispersion in patients with hypertension [in Russian]. Kardiologiia. 2008;48:42–5.

    CAS  PubMed  Google Scholar 

  • United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of microvascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703.

    Article  Google Scholar 

  • Valsartan Heart Failure Trial Investigators, Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345:1667–75.

    Article  CAS  PubMed  Google Scholar 

  • Valimaki ML, Harno K. Lipoprotein lipids and apoproteins during beta-blocker administration: comparison of penbutolol and atenolol. Eur J Clin Pharmacol. 1986;30:17.

    Article  CAS  PubMed  Google Scholar 

  • van Veldhuisen DJ, Cohen-Solal A, Bohm MA, Seniors Investigators, et al. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with Heart Failure). J Am Coll Cardiol. 2009;53:2150–8.

    Article  PubMed  Google Scholar 

  • Wallin JD, O’Neill WM. Labetalol: current research and therapeutic status. Arch Intern Med. 1983;143:485.

    Article  CAS  PubMed  Google Scholar 

  • Warltier DC, Hardman HJ, Brooks HL, et al. Transmural gradient of coronary blood flow following dihydropyridine calcium antagonists and other vasodilator drugs. Basic Res Cardiol. 1983;78:644.

    Article  CAS  PubMed  Google Scholar 

  • Weintraub WS, Akizuki S, Agarwal JB, et al. Comparative effects of nitroglycerin and nifedipine on myocardial blood flow and contraction during flow-limiting coronary stenosis in the dog. Am J Cardiol. 1982;50:281.

    Article  CAS  PubMed  Google Scholar 

  • Wheat Jr MW. Treatment of dissecting aneurysms of the aorta: current status. Prog Cardiovasc Dis. 1973;16:87.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Ottawa The Ottawa Hospital, Ottawa, ON, Canada

    M. Gabriel Khan MD, FRCPC, FRCP (London), FACC

Authors
  1. M. Gabriel Khan MD, FRCPC, FRCP (London), FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Khan, M.G. (2015). Beta-Blockers. In: Cardiac Drug Therapy. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-962-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-962-4_1

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-961-7

  • Online ISBN: 978-1-61779-962-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation